1. Home
  2. LPG vs ADMA Comparison

LPG vs ADMA Comparison

Compare LPG & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dorian LPG Ltd.

LPG

Dorian LPG Ltd.

SELL

Current Price

$54.97

Market Cap

1.8B

ML Signal

SELL

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

SELL

Current Price

$10.59

Market Cap

2.0B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
LPG
ADMA
Founded
2013
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.0B
IPO Year
2014
2012

Fundamental Metrics

Financial Performance
Metric
LPG
ADMA
Price
$54.97
$10.59
Analyst Decision
Buy
Buy
Analyst Count
5
4
Target Price
★ $54.60
$17.00
AVG Volume (30 Days)
541.7K
★ 3.1M
Earning Date
11-05-2026
11-04-2026
Dividend Yield
★ 5.09%
N/A
EPS Growth
★ 112.15
N/A
EPS
★ 3.24
0.35
Revenue
★ $481,511,242.00
$42,219,783.00
Revenue This Year
$32.64
$4.93
Revenue Next Year
N/A
$17.59
P/E Ratio
★ $17.90
$29.54
Revenue Growth
36.27
★ 43.85
52 Week Low
$23.76
$7.21
52 Week High
$59.97
$20.46

Technical Indicators

Market Signals
Indicator
LPG
ADMA
Relative Strength Index (RSI) 48.27 65.11
Support Level $52.09 $9.23
Resistance Level $59.97 $11.42
Average True Range (ATR) 2.00 0.39
MACD -0.23 0.05
Stochastic Oscillator 29.90 98.54

Price Performance

Historical Comparison
LPG
ADMA

About LPG Dorian LPG Ltd.

Dorian LPG Ltd is an international liquefied petroleum gas shipping company focused on owning and operating gas carriers, or VLGCs. The company currently owns and operates around 22 modern VLGCs, including nineteen new fuel-efficient 84,000 cbm ECO-design VLGCs. Dorian LPG has offices in Connecticut, USA, London, United Kingdom, and Athens, Greece. IT operates in one reportable segment, the international transportation of LPG.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.

Share on Social Networks: